INS and type 2 diabetes mellitus: The diabetes control in subjects using insulin for the treatment study (DIAINFORM) showed that the frequency of acceptable metabolic control (HbA1c <7% (53 mmol/mol)) in patients with T2D treated with insulin was 37.1% [76].